Literature DB >> 17091285

[Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].

F Lordick1, J R Siewert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17091285     DOI： 10.1007/s00104-006-1249-5

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  2 in total

1.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

2.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
  2 in total
  4 in total

1.  [Esophageal carcinoma. Results after esophageal resection].

Authors:  I Gastinger
Journal:  Chirurg       Date:  2008-01       Impact factor: 0.955

2.  Lymph node dissection in curative gastrectomy for advanced gastric cancer.

Authors:  Shigeyuki Tamura; Atsushi Takeno; Hirofumi Miki
Journal:  Int J Surg Oncol       Date:  2011-06-14

3.  Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.

Authors:  Jinwan Wang; Ruihua Xu; Jian Li; Yuxian Bai; Tianshu Liu; Shunchang Jiao; Guanghai Dai; Jianming Xu; Yunpeng Liu; Nanfeng Fan; Yongqian Shu; Yi Ba; Dong Ma; Shukui Qin; Leizhen Zheng; Weichang Chen; Lin Shen
Journal:  Gastric Cancer       Date:  2015-01-21       Impact factor: 7.370

Review 4.  Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Authors:  Daniel Buergy; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Stefan Haneder; Henrik Michaely; Frederik Wenz; Judit Boda-Heggemann
Journal:  Radiat Oncol       Date:  2012-11-16       Impact factor: 3.481
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.